secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2026-05-11T20:08:27+00:00
Accession:  0001773751-26-000074
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers Q1 net loss $92.1M; revenue $608M (+4% YoY); raises FY2026 guidance to $2.8B-$3.0B
--------------------------------------------------------------------------------

- Revenue $608.1M (+4% YoY); net loss $92.1M vs net income $49.5M in Q1 2025.
- Adjusted EBITDA $44.3M vs $91.1M; gross margin fell to 65% from 73%.
- Subscribers 2.584M (+9% YoY); monthly revenue per subscriber $80 (-6%).
- FY2026 revenue guidance raised to $2.8B–$3.0B; Adjusted EBITDA guidance $275M–$350M.
- Proposed acquisition of Eucalyptus expected mid-2026; not included in guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000074/0001773751-26-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000177375126000074/hims-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001773751-26-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer